Literature DB >> 15028022

Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: Relationship between its expression and prognosis.

Katsuhito Kamimura1, Hiroshi Hojo, Masafumi Abe.   

Abstract

Protein kinase C (PKC) enzymes play a major role in signal transduction and contribute to the regulation of cellular differentiation and proliferation. However, little is known about subtype-specific intracellular expression of PKC in human malignant lymphoma. To characterize the relationship between expression of PKC and B-cell lymphomas based on the different subspecies, we investigated the expression of four subspecies (alpha, beta II, gamma and delta) in five cases of reactive lymphoid tissues, 77 cases of human B-cell lymphoma and 17 human lymphoma cell lines. In the reactive lymphoid tissues, PKC beta II-positive cells were found in the mantle zones and marginal zones, and centroblasts and centrocytes in the germinal centers showed cytoplasmic staining with strong intensity against PKC delta. The present study is the first report to examine the expression of PKC delta in reactive lymphoid tissues. In interfollicular areas, a small number of T-cells were positive for PKC alpha. Protein kinase C gamma-positive cells were not found in these lymphoid tissues. Eight cases of Burkitt lymphoma (BL) (8/10; 80%) showed the overexpression of PKC alpha (P < 0.01), but other B-cell lymphoma cases except three cases of diffuse large B-cell lymphoma did not express PKC alpha. In addition, six and eight out of nine BL cell lines expressed the protein and mRNA of PKC alpha, respectively. These results indicate that PKC alpha was predominantly expressed on BL in comparison with other types of lymphoma. The expression of PKC gamma was observed in only five cases of BL. The overall survival of PKC gamma-positive BL was significantly better than that of PKC gamma-negative BL (P < 0.05). The expression of PKC gamma seems to be associated with a better prognosis in the limited number of BL cases in the present study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028022     DOI: 10.1111/j.1440-1827.2004.01612.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  6 in total

1.  Ellagic acid inhibits PKC signaling by improving antioxidant defense system in murine T cell lymphoma.

Authors:  Sudha Mishra; Manjula Vinayak
Journal:  Mol Biol Rep       Date:  2014-02-27       Impact factor: 2.316

2.  Expression of protein kinase C family in human hepatocellular carcinoma.

Authors:  Hsiu-Chin Lu; Fen-Pi Chou; Kun-Tu Yeh; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

3.  Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway.

Authors:  Sudha Mishra; Manjula Vinayak
Journal:  Mol Biol Rep       Date:  2012-10-31       Impact factor: 2.316

Review 4.  Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling.

Authors:  Catríona M Dowling; Patrick A Kiely
Journal:  Cancers (Basel)       Date:  2015-07-15       Impact factor: 6.639

5.  Sequence based analysis of U-2973, a cell line established from a double-hit B-cell lymphoma with concurrent MYC and BCL2 rearrangements.

Authors:  Sean D Hooper; Xiang Jiao; Elisabeth Sundström; Farah L Rehman; Christian Tellgren-Roth; Tobias Sjöblom; Lucia Cavelier
Journal:  BMC Res Notes       Date:  2012-11-22

6.  Protein kinase C: an attractive target for cancer therapy.

Authors:  Barbara Marengo; Chiara De Ciucis; Roberta Ricciarelli; Maria A Pronzato; Umberto M Marinari; Cinzia Domenicotti
Journal:  Cancers (Basel)       Date:  2011-02-01       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.